Our 2024 Partners
SCARLETRED
Lead & Hosting Partner
SCARLETRED is the worldwide leader in standardized skin imaging and AI powered objective skin analysis. We develop and deliver cutting edge software products and services to biopharma-, biotech- , cosmetics companies, clinical research organisations and health care experts. Our certified, ICH-GCP and EU-GDPR compliant mobile medical device software Scarletred® Vision is the first digital solution solving the problem of lacking standardization and subjective visual skin assessment in pre-clinical, clinical, and post-marketing studies. The highly scalable software platform works infrastructure as well as location independent and enables on-site and home-based monitoring of dermatologic disease as well as digital analysis of skin drug related effects. It it easy to use and reduces development time and opportunity cost in clinical RnD projects. Our digital Products and Services are delivered worldwide from our offices in Europe and USA via flexible Software as a Service (SaaS) agreements.
QuantifiCare
Innovation Partner
QuantifiCare is an Imaging CRO specialized in the management and analysis of 2D and 3D digital images in Phase I-IV multicenter and decentralized trials. With over 20 years of experience in clinical research and medical image processing, QuantifiCare has developed a strong expertise across the fields of dermatology, aesthetics, wound care and oncology. The company operates internationally from its offices in the USA, Europe, South America and Asia.
Human Metabolome Technologies-America (HMT-A)
Innovation Partner
HMT-A is a complete metabolomics analysis provider operating for over 20 years. Our unique platforms provide high resolution separation and mass detection with an internal library over 4,000 metabolites, peptides and lipids.
HMT-A provides protocols for skin testing using skin strips, with a complete statistical and biological interpretation of results. We also provide full profiling of cells, tissues and biofluids.
Dow Development Laboratories
Exhibition Partner
Dow Development Lab’s develops, manufactures and tests topical drug products for dermatology. Products are designed with the patient in mind. The formulation, analytical, production, quality, and clinical labeling groups have decades of experience moving products quickly toward regulatory approval. DDL works seamlessly with its parent company Symbio, a specialty CRO with over 20 years of success in conducting clinical trials, to rapidly advance dermatological programs through all stages of clinical development.
Therapeutics Inc.
Exhibition Partner
San Diego based, Therapeutics, Inc., The Dermatology CRO was founded in 1997. Approximately 90% of our activities are focused on developing dermatology products. TI is the only dermatology focused CRO that provides all services required to move a product concept through non-clinical and clinical stages to FDA approval. During the last 5 years: TI managed >12,000 subjects in >80 clinical studies and filed 18 INDs and IDEs in a variety of drug, device and biologic programs.
Ascilion
Event Partner
Ascilion is the world leader in sampling of dermal interstitial fluid (dISF). A pioneer within hollow microneedle technology since 2012, Ascilion has developed the only solution available for sampling of practical amounts of pure dISF, enabling complete quantitative biomarker evaluation. Ascilion’s product PELSA is painless, quick, easy to use and leaves no residual mark on the skin. PELSA is available for research use and for pharmaceutical or cosmetic testing applications.
Altasciences
Event Partner
Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. We are leaders in dermal research and offer a wide range of expertise in dermal safety testing. We conduct GLP and non-GLP toxicology studies to support 505(b)(2) and new chemical entity regulatory filings and bring your molecule from discovery through clinical trials to proof-of-concept, and beyond.
Eurofins Bioskin
Event Partner
Eurofins bioskin is a full-service Clinical Research Organization (CRO) specialized in the field of dermatology and located in Germany. Since its inception in 1992, bioskin has been recognized as a valuable partner for clinical trials in dermatological indications. Starting as a small Contract Research Organization (CRO) for conducting early phase safety and efficacy trials, bioskin has grown into a full-service CRO offering dermatologic consulting and all services for management of Phase I-III drug trials and medical device studies. As of August 1, 2021 bioskin has become part of the Eurofins network of companies. By joining the Eurofins network, we strengthen our position as a leading provider of clinical dermatological trials for pharmaceuticals and medical devices.
CPL
Event Partner
CPL is a leading CDMO providing product development and commercial manufacturing of non-sterile topical and liquid pharmaceutical products. Our manufacturing and testing facilities are approved by FDA, Health Canada, ANVISA, and can support North American, EU, and other global markets. Our experience includes NDA's, ANDA's, and OTC products, and we provide clinical trial materials through commercial product manufacturing. CPL has completed investments in new manufacturing technologies and tube and bottle filling capabilities. From product development to commercial production, CPL provides turnkey solutions to our customers all under one location.
Nuvisan
Event Partner
NUVISAN, a Europe-based CRO/CDMO, provides tailored solutions along the drug development chain with a unique expertise in dermatology and topical formulations. Our capabilities start from drug discovery, with competence in high-throughput screening, preclinical models for pharmacokinetics and efficacy, and advanced tools for skin permeation studies. Concerning drug development, we provide integrated support from tailored API formulation to GMP-certified clinical trial batches. Known for flexibility and close collaboration, NUVISAN joined ALS Limited in April 2024, expanding our reach to 350+ offices and 19,000 staff worldwide.
TFS HealthScience
Event Partner
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With over 800 professionals operating across 40 countries, TFS delivers tailored clinical research services in specialized therapeutic areas, including dermatology, internal medicine, neuroscience, oncology, and ophthalmology. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO.